Another MESA grantee has finalised its projects and shared the findings: the MESA-funded IVERMAL Study, a randomised, double-blind, placebo-controlled trial conducted in Kenya and led by the Liverpool School of Tropical Medicine (LSTM) has produced new evidence that supports the use of ivermectin as a tool for malaria elimination.
T'is the season for self-reflection over results of the past year and gearing up on activities of the new. We at the Malaria Eradication Scientific Alliance (MESA) are also looking ahead and now invite innovative solution partners to our Request for Proposal (RFP).
With 'MalariaX: Defeating Malaria from the Genes to the Globe', a free, self-paced online course, learners can explore cutting-edge science and examine policies needed to control and eliminate malaria.
More than 180 scientists, malaria programme managers and policy makers from around the world have come together through a consultative process to update the research agenda for malaria elimination and eradication, first produced in 2011. The outcome is a series of seven ‘malERA Refresh’ (malaria eradication research agenda) papers that have undergone expert peer review and will soon be published in an open access journal.
“As a researcher working in a country that has decided to take on the challenge of eliminating malaria, the knowledge in the paper is enriching”. This is how Sandra Chishimba chose her ‘Top Pick’ article for World Malaria Day 2017. MESA (Malaria Eradication Scientific Alliance) asked five experts what recent paper has helped them in their effort to outsmart malaria.
In February 2017, malaria experts from around the world gathered in Kampala, Uganda to attend "Malaria: From Innovation to Eradication", a conference organized by Keystone Symposia in collaboration with MESA. Eight scientists shared their cutting-edge research with MESA, on film.